Trials / Completed
CompletedNCT02961985
Myocardial Infarction Register of the Saarland
Myokardinfarkt-Register Des Saarlandes (MIR-SL)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 455 (actual)
- Sponsor
- Stiftung Institut fuer Herzinfarktforschung · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland.
Detailed description
The Myocardial Infarction Register Saarland (MIR-SL), is intended to collect data about the treatment of patients suffering from ST-elevation myocardial infarction (STEMI). It aims to provide current data on the implementation of guidelines for both, the interventional and adjuvant drug therapy of STEMI in daily clinical practice in the Saarland. In order to obtain representative data for the Saarland, preferably all consecutive patients should be documented comprehensively in the University Hospital of the Saarland, the non-university hospitals with cardiac catheterization laboratory as well as in hospitals without cardiac catheterization laboratory . MIR-SL is attended by all 22 hospitals in Saarland, that treat patients with acute STEMI. A follow-up will be carried out after three months, 12 months and five years.
Conditions
Timeline
- Start date
- 2016-10-01
- Primary completion
- 2018-07-19
- Completion
- 2023-03-29
- First posted
- 2016-11-11
- Last updated
- 2023-04-14
Locations
3 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT02961985. Inclusion in this directory is not an endorsement.